Detalles de la búsqueda
1.
Efficacy of Bezlotoxumab in Trial Participants Infected With Clostridioides difficile Strain BI Associated With Poor Outcomes.
Clin Infect Dis
; 73(9): e2616-e2624, 2021 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32735653
2.
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection.
N Engl J Med
; 376(4): 305-317, 2017 01 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-28121498
3.
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence.
Clin Infect Dis
; 67(5): 649-656, 2018 08 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-29538686
4.
Bezlotoxumab for Clostridium difficile Infection Complicating Inflammatory Bowel Disease.
Gastroenterology
; 155(4): 1270-1271, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30227108
5.
Switch to fixed-dose doravirine (100 mg) with islatravir (0·75 mg) once daily in virologically suppressed adults with HIV-1 on antiretroviral therapy: 48-week results of a phase 3, randomised, open-label, non-inferiority trial.
Lancet HIV
; 11(6): e369-e379, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38734015
6.
Switch to fixed-dose doravirine (100 mg) with islatravir (0·75 mg) once daily in virologically suppressed adults with HIV-1 on bictegravir, emtricitabine, and tenofovir alafenamide: 48-week results of a phase 3, randomised, controlled, double-blind, non-inferiority trial.
Lancet HIV
; 11(6): e357-e368, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38734016
7.
Brief Report: Efficacy and Safety of Oral Islatravir Once Daily in Combination With Doravirine Through 96 Weeks for Treatment-Naive Adults With HIV-1 Infection Receiving Initial Treatment With Islatravir, Doravirine, and Lamivudine.
J Acquir Immune Defic Syndr
; 91(1): 68-72, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35972855
8.
Islatravir in combination with doravirine for treatment-naive adults with HIV-1 infection receiving initial treatment with islatravir, doravirine, and lamivudine: a phase 2b, randomised, double-blind, dose-ranging trial.
Lancet HIV
; 8(6): e324-e333, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34000227
9.
Influence of Diagnostic Method on Outcomes in Phase 3 Clinical Trials of Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection: A Post Hoc Analysis of MODIFY I/II.
Open Forum Infect Dis
; 6(8)2019 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31375837
10.
Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children.
Pediatr Infect Dis J
; 24(8): 665-9, 2005 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16094217
11.
An open randomized study of inactivated hepatitis A vaccine administered concomitantly with typhoid fever and yellow fever vaccines.
J Travel Med
; 9(2): 66-70, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-12044272
12.
Field performance of VAQTA (inactivated, purified hepatitis a vaccine) in Chinese children in Jiangsu.
Southeast Asian J Trop Med Public Health
; 35(4): 949-53, 2004 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-15916096
13.
Comparison of the safety and immunogenicity of a refrigerator-stable versus a frozen formulation of ProQuad (measles, mumps, rubella, and varicella virus vaccine live).
Pediatrics
; 119(6): e1299-305, 2007 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-17502347
14.
Field performance of VAQTA (inactivated, purified hepatitis a vaccine) in Chinese children in Jiangsu.
Southeast Asian J Trop Med Public Health
; 2004 Dec; 35(4): 949-53
Artículo
en Inglés
| IMSEAR | ID: sea-34236
Resultados
1 -
14
de 14
1
Próxima >
>>